Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma

Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.19-26663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Related search

Circulating miR-499 as a Potential Biomarker for Acute Myocardial Infarction

Annals of Translational Medicine
Medicine
2016English

Selective Laser Trabeculoplasty as Primary Treatment for Open-Angle Glaucoma

Archives of Ophthalmology
2003English

Secreted miR-210-3p as Non-Invasive Biomarker in Clear Cell Renal Cell Carcinoma

European Urology, Supplements
Urology
2018English

A Prospective Comparison of Chronic Primary Angle-Closure Glaucoma Versus Primary Open-Angle Glaucoma in Singapore

Singapore Medical Journal
Medicine
2013English

Clustered microRNAs Hsa-miR-221-3p/Hsa-miR-222-3p and Their Targeted Genes Might Be Prognostic Predictors for Hepatocellular Carcinoma

Journal of Cancer
Oncology
2019English

Primary Open-Angle Glaucoma and Serum Lipids

Bosnian Journal of Basic Medical Sciences
Medicine
2009English

Genetic Risk of Primary Open-Angle Glaucoma

Archives of Ophthalmology
1998English

The Potential Role of Long Noncoding RNAs in Primary Open-Angle Glaucoma

2019English

Association betweenSRBD1andELOVL5Gene Polymorphisms and Primary Open-Angle Glaucoma

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy